Adding a Glucagon like peptide‐1 analogue (GLP‐1RA) has a favourable effect on mortality and cardiovascular events among insulin‐treated patients with Type 2 diabetes: a large retrospective UK cohort study

Mar-17

Cardiovascular Endocrinology Pharmacoepidemiology

AUTHORS : Dr Iskandar Idris, University of Nottingham, Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Royal Derby Hospital , Uttoxeter Road, Derby DE22 3DT – Email: Iskandar.Idris@nottingham.ac.uk – Profile: https://www.nottingham.ac.uk/medicine/people/iskandar.idris – Cannot find much information on Uchenna Anyanwagu, Division of Medical Sciences & Graduate Entry Medicine, School of Medicine, University of Nottingham, United Kingdom – Profile (publons): https://publons.com/researcher/1239992/uchenna-anyanwagu/

JOURNAL : Diabetic Medicine

REFERENCE: 34(S1):17

DOI : 10.1111/dme.6_13303

Adding a Glucagon like peptide‐1 analogue (GLP‐1RA) has a favourable effect on mortality and cardiovascular events among insulin‐treated patients with Type 2 diabetes: a large retrospective UK cohort study

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study